XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 63,619 $ 22,954
Short-term investments 156,024 147,355
Accounts receivable, net 34,318 32,917
Inventory 16,740 23,969
Income taxes receivable 7,813 6,395
Current derivative assets 11,133 0
Other current assets 19,741 3,839
Total current assets 309,388 237,429
Intangible assets, net 274,905 299,606
Goodwill 105,250 103,370
Long-term portion of financial royalty assets, net 199,251 62,291
Noncurrent derivative assets 19,246 3,531
Property and equipment, net 15,094 15,607
Operating lease right-of-use assets 7,157 6,062
Finance lease right-of-use assets 2,940 3,393
Equity method investment in Primrose Bio 1,245 12,595
Other investments 11,908 36,726
Deferred income taxes, net 78 214
Other assets 8,404 6,392
Total assets 954,866 787,216
Current liabilities:    
Accounts payable 4,694 2,427
Accrued liabilities 15,600 12,467
Income taxes payable 2,108 0
Deferred revenue 1,152 1,222
Current contingent liabilities 128 256
Current operating lease liabilities 1,066 403
Current finance lease liabilities 24 7
Total current liabilities 24,772 16,782
Long-term deferred revenue 2,508 1,444
Long-term contingent liabilities 3,863 2,942
Long-term operating lease liabilities 6,267 5,755
Deferred income taxes, net 46,404 31,622
Other long-term liabilities 29,874 27,758
Total liabilities 113,688 86,303
Commitments and contingencies
Stockholders' equity:    
Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at September 30, 2024 and December 31, 2023 0 0
Common stock, $0.001 par value; 60,000 shares authorized; 18,760 and 17,556 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 19 18
Additional paid-in capital 309,341 198,696
Accumulated other comprehensive loss 1,746 (817)
Retained earnings 530,072 503,016
Total stockholders' equity 841,178 700,913
Total liabilities and stockholders' equity $ 954,866 $ 787,216